Detalhe da pesquisa
1.
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial.
Ann Oncol
; 33(10): 1021-1028, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772665
2.
The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer.
Ann Oncol
; 33(6): 593-601, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219776
3.
Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin.
Gynecol Oncol
; 153(2): 223-229, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765148
4.
Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety.
Ann Oncol
; 27(6): 1013-1019, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26961146
5.
A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer.
Gynecol Oncol
; 141(1): 108-12, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27016236
6.
A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours.
Br J Cancer
; 103(1): 12-7, 2010 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-20588278
7.
Potential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma.
Int J Gynecol Cancer
; 18(5): 934-6, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18081793
8.
Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype.
Clin Cancer Res
; 5(11): 3445-53, 1999 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-10589757
9.
Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation.
Curr Cancer Drug Targets
; 3(1): 1-19, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12570657
10.
Randomized placebo-controlled trial of the activity of the morphine glucuronides.
Clin Pharmacol Ther
; 68(6): 667-76, 2000 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-11180027
11.
A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma.
Lung Cancer
; 31(1): 67-72, 2001 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11162868
12.
Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype.
Anticancer Res
; 22(4): 1933-41, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12174867
13.
Limited phase I study of morphine-3-glucuronide.
J Pharm Sci
; 90(11): 1810-6, 2001 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-11745739
14.
Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel.
Int J Gynecol Cancer
; 10(1): 33-41, 2000 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11240649
15.
Ovarian cancer: an update on genetics and therapy.
Compr Ther
; 24(10): 477-87, 1998 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-9801846
16.
Bevacizumab and ovarian cancer.
Drugs Today (Barc)
; 47(9): 669-81, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21971541
17.
Nodal metastasis is highly consistent in squamous cell carcinoma of the vulva.
J Clin Oncol
; 19(10): 2767-8, 2001 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11352972
18.
Nodal metastasis is highly consistent in squamous cell carcinoma of the vulva.
J Clin Oncol
; 19(8): 2364-5, 2001 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11304789
19.
Clinical course of stage IV epithelial ovarian cancer.
J Clin Oncol
; 17(10): 3361-2, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10506641
20.
Double modulation of 5-fluorouracil with interferon alpha-2a and high-dose leucovorin in advanced neuroendocrine tumours.
Eur J Cancer
; 34(13): 2133-4, 1998 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-10070325